JMJohn Mokua Mose

John Mokua Mose

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John Mokua Mose has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • John Maina Kagira

    Department of Animal Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya

    4 shared publications
  • Naomi Maina

    Pan African University Institute for Basic Sciences, Technology and Innovation (PAUSTI), JKUAT Main Campus, P.O. Box: 62000-00200, Nairobi, Kenya

    4 shared publications
  • Maina Ngotho

    Department of Animal Health & Production, Mount Kenya University, Thika, Kenya

    3 shared publications
  • Simon Karanja

    Department of Environmental Health and Disease Control, School of Public Health, College of Health Sciences (COHES), Jomo Kenyatta University of Agriculture and Technology, Nairobi-Kenya

    3 shared publications
  • Alfred Orina Isaac

    2 shared publications
  • David Muchina Kamau

    Department of Public Health, Jomo Kenyatta University of Agriculture and Technology (JKUAT), P.O. Box 62000-00200, Nairobi, Kenya

    2 shared publications

Latest Publications

  • Open Access

    Amoxicillin and cotrimoxazole-driven dysbiosis disrupted blood cell levels, cytokine balance and induced oxido-nitrosative stress in young mice

    by Kiptoo K. Cosmas, Silas Kiruki, Olivia A. Njiri, Grace K. Nyambati, John Mokua Mose, Omwenga Isaac, Alfred Orina Isaac, James Nyabuga Nyariki


  • Open Access

    Coinfection with Schistosoma mansoni Enhances Disease Severity in Human African Trypanosomiasis

    by Nancy S. Mitalo, Naomi N. Waiganjo, John Mokua Mose, David O. Bosire, James O. Oula, Alfred Orina Isaac, James Nyabuga Nyariki

    Introduction. Human African trypanosomiasis (HAT) and schistosomiasis are neglected parasitic diseases found in the African continent. This study was conducted to determine how primary infection with Schistosoma mansoni affects HAT disease progression with a secondary infection with Trypanosoma brucei rhodesiense (T.b.r) in a mouse model. Methods. Female BALB-c mice (68weeks old) were randomly divided into four groups of 12 mice each. The different groups were infected with Schistosoma mansoni (100 cercariae) and Trypanosoma brucei rhodesiense (5.0×104) separately or together. Twenty-one days after infection with T.b.r, mice were sacrificed and samples were collected for analysis. Results. The primary infection with S. mansoni significantly enhanced successive infection by the T.b.r; consequently, promoting HAT disease severity and curtailing host survival time. T.b.r-induced impairment of the neurological integrity and breach of the blood-brain barrier were markedly pronounced on coinfection with S. mansoni. Coinfection with S. mansoni and T.b.r resulted in microcytic hypochromic anemia characterized by the suppression of RBCs, hematocrit, hemoglobin, and red cell indices. Moreover, coinfection of the mice with the two parasites resulted in leukocytosis which was accompanied by the elevation of basophils, neutrophils, lymphocytes, monocytes, and eosinophils. More importantly, coinfection resulted in a significant elevation of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total bilirubin, creatinine, urea, and uric acid, which are the markers of liver and kidney damage. Meanwhile, S. mansoni-driven dyslipidemia was significantly enhanced by the coinfection of mice with T.b.r. Moreover, coinfection with S. mansoni and T.b.r led to a strong immune response characterized by a significant increase in serum TNF-α and IFN-γ. T.b.r infection enhanced S. mansoni-induced depletion of cellular-reduced glutathione (GSH) in the brain and liver tissues, indicative of lethal oxidative damage. Similarly, coinfection resulted in a significant rise in nitric oxide (NO) and malondialdehyde (MDA) levels. Conclusion. Primary infection with S. mansoni exacerbates disease severity of secondary infection with T.b.r in a mouse model that is associated with harmful inflammatory response, oxidative stress, and organ injury.


  • Open Access

    A Review on the Present Advances on Studies of Toxoplasmosis in Eastern Africa

    by John Mokua Mose, John Maina Kagira, David Muchina Kamau, Naomi Wangari Maina, Maina Ngotho, Simon Muturi Karanja

    Toxoplasmosis is a zoonotic infection caused by the protozoan parasite, Toxoplasma gondii. It was discovered over 100 years ago and is credited as the most successful parasitic organism worldwide, able to infect and multiply in all warm blooded animals including an estimated 2.3 billion people. Toxoplasmosis is asymptomatic in immunocompetent individuals. Infection in the developing fetus and immunocompromised individuals can cause severe clinical disease. Toxoplasmosis is also a major cause of reproductive failure in livestock. The economic impact of toxoplasmosis is believed to be substantial. Factors associated with toxoplasmosis infection have been defined. Eastern Africa region is a high‐risk area mainly due to the close association of humans and livestock as well as sociocultural practices, poor environmental hygiene, and poverty. The present paper provides a narrative review of published data on toxoplasmosis in Eastern Africa.


  • Open Access

    Organ Pathology and Associated IFN-γ and IL-10 Variations in Mice Infected with Toxoplasma gondii Isolate from Kenya

    by John Mokua Mose, David Muchina Kamau, John Maina Kagira, Naomi Maina, Maina Ngotho, Lucy Mutharia, Simon Muturi Karanja

    Toxoplasma gondii is an important foodborne opportunistic pathogen that causes a severe disease in immunocompromised patients. The pathology and immune responses associated with the ensuing disease have not been well described in strains from different parts of the world. The aim of the present study is to determine the IFN-γ and IL-10 variations and organ pathology in immunocompetent and immunocompromised mice infected with T. gondii isolated from a Kenyan chicken. Two groups of BALB/c mice were infected with T. gondii cysts and administered with dexamethasone (DXM) in drinking water. Other two groups: infected untreated and uninfected mice were kept as controls. The mice were euthanized at various time points: blood collected for serum and assayed for IFN-γ and IL-10 variations. After infection, significant (p<0.05) elevated levels of IFN-γ and IL-10 were observed. A significant decline in IFN-γ and IL-10 levels (p<0.05) was observed after dexamethasone treatment. Histological sections in the liver, heart, and spleen of the mice administered with DXM revealed various degrees of inflammation characterized by infiltration of inflammatory cells. The dexamethasone-treated mice presented with progressively increased (p<0.001) inflammatory responses is compared with the infected untreated mice.


  • Open Access

    Evaluation of Trypanocidal Activity of Bidens pilosa and Physalis peruviana Against Trypanosoma brucei rhodesiense

    by Lilian Mwende Mwaniki, John Mokua Mose, Titus Mutwiri, James Mulinge Mbithi

    Trypanosomiasis is a protozoan disease that causes death and morbidity to man, and also severely limits livestock productivity in endemic areas. It is caused by different species of trypanosomes that occur in Africa, South America and Asia. Although chemotherapy is the main method of trypanosomiasis control, the few drugs in the market are faced with challenges of drug resistance, high toxicity and very costly. There is also no likelihood of a vaccine to control new outbreaks and there are no new drugs in the market. Herbal medicines are increasingly being used as an alternative solution to the control of trypanosomiasis in endemic areas. These are cost effective and economic friendly. The purpose of this study was to evaluate trypanocidal activity of Bidens Pilosa and Physalis peruviana using in-vitro and in-vivo protocols. The in-vitro trials are carried out using 96 well plates where the trypanocidal activities of the plant extracts were evaluated by calculating the minimum inhibition concentration (MIC). Toxicity of the herbal extract was determined by monitoring survival, weight change, lethargy and difficulty in breathing. Parasitemia development after extract administration was used as parameters to test the test compound for trypanocidal activity. In vitro results revealed that bidens pilosa had the highest activity with an MIC of 125µg/ml after 48 hours of incubation against Trypanosoma brucei rhodensiense isolated from a patient in busia (KETRI 3684). Toxicity results showed that a dosage level of above 1000mg/kg body weight (highest toxicity trial dose used) of bidens pilosa caused clinical signs such as difficulty in breathing, lethargy, raised hair, loss of weight and death within five days. In-vivo results revealed that Bidens pilosa had some trypanocidal effect but did not perform better than the standard drugs. It is recommend that repeat therapy could be done to clear the parasites completely. Combined therapy of bidens pilosa and physalis peruviana was recommended to see if results can create a rationale for combination therapy in elimination of the parasites. This study has showed that Bidens pilosa and Physalis peruviana have trypanocidal potential.


  • Open Access

    Development of Neurological Mouse Model for Toxoplasmosis Using Toxoplasma gondii Isolated from Chicken in Kenya

    by John Mokua Mose, David Muchina Kamau, John Maina Kagira, Naomi Maina, Maina Ngotho, Adele Njuguna, Simon Muturi Karanja

    Animal models for the toxoplasmosis are scarce and have limitations. In this study, a neurological mouse model was developed in BALB/c mice infected intraperitoneally with 15 cysts of a Toxoplasma gondii isolate. The mice were monitored for 42 days and euthanized at different time points. Another group of mice were orally treated with dexamethasone (DXM: 2.66 mg/kg daily, 5.32 mg/kg daily) at 42 days after infection and monitored for a further 42 days. A mortality rate of 15% and 28.6% was observed in mice given 2.66 mg/kg/day and 5.32 mg/kg/day of DXM, respectively. The mean cyst numbers in the brain of DXM treated mice increased up to twofold compared with chronically infected untreated mice. Infections up to 42 days were associated with an increase in both IgM and IgG levels but following dexamethasone treatment, IgM levels declined but IgG levels continued on rising. The brain of toxoplasmosis infected mice showed mononuclear cellular infiltrations, neuronal necrosis, and cuffing. The severity of pathology was higher in mice treated with dexamethasone compared to the positive control groups. The findings of this study demonstrate that DXM-induced reactivation of chronic toxoplasmosis may be a useful development of laboratory animal model in outbred mice used for in vivo studies.


  • Open Access

    Detection of NaturalToxoplasma gondiiInfection in Chicken in Thika Region of Kenya Using Nested Polymerase Chain Reaction

    by John Mokua Mose, John Maina Kagira, Simon Muturi Karanja, Maina Ngotho, David Muchina Kamau, Adele Nyambura Njuguna, Naomi Wangari Maina

    The detection ofToxoplasma gondiiin free-range chickens is a good indicator of possible risk to human beings. The aim of this study was to investigate the occurrence ofT. gondiiin free-range chicken using polymerase chain reaction (PCR). Brain samples from 105 free-range chickens from three administrative areas in Thika region, Kenya, were collected, DNA-extracted, and analyzed using PCR to detect presence ofT. gondii. The overall prevalence ofT. gondiiin all the three areas was 79.0% (95% CI: 70.0–86.4%) and the prevalence across the three areas was not significantly different (P=0.5088;χ2=1.354). Female chickens had higher (79.4%) prevalence than males (78.6%), although the difference was not significant (P=0.922,χ2= 0.01). However, chickens that were more than 2 years old had significantly (P=0.003;χ2= 11.87) higher prevalence compared to younger ones. The study indicates that there was a high occurrence ofT. gondiiinfection in free-range chickens from Thika region and that the infection rate is age dependent. Further studies should be carried out to determine the possible role of roaming chickens in the epidemiology of the disease among humans in the area.